Dopamine Transporter Imaging-Based Radiomics for Predicting 4-Year Motor Progression(Unified Parkinsons Disease Rating Scale Part III)in Parkinsons DiseaseOA
Background:Parkinson''s disease(PD)shows substantial heterogeneity in motor progression,and reliable early prediction remains challenging.Dopamine transporter(DAT)imaging reflects presynaptic dopaminergic degeneration but is typically analyzed using simplified metrics that may not capture spatial heterogeneity.This study aims to evaluate whether magnetic resonance imaging(MRI)-guided DAT radiomics combined with machine learning can predict 4-year motor progression in PD.Methods:In this retrospective study,120 patients from the Parkinson''s Progression Markers Initiative were included.Motor progression was defined using the 4-year change in Movement Disorder Society–Unified Parkinson''s Disease Rating Scale part III(UPDRS-III)score.Bilateral caudate nuclei and putamina were manually delineated on T1-weighted MRI and transferred to co-registered DAT images.Radiomics features were extracted using PyRadiomics.Twenty base models were constructed by combining two feature-selection methods with 10 classifiers,and Top-2 voting fusion models were developed.Clinical-variable,levodopa equivalent daily dose(LEDD)-adjusted,and clinical-radiomics models were also evaluated.Results:The best-performing base model achieved a mean area under the receiver operating characteristic curve(AUROC)of 0.736.Fusion models improved discrimination,with the best soft-voting model achieving an AUROC of 0.920 and balanced accuracy(BACC)of 0.734.A more balanced fusion model achieved an AUROC of 0.902 with higher sensitivity(0.818).The clinical-radiomics model showed only a slight AUROC increase over the clinical-only model,and adding Year-4 LEDD did not materially alter radiomics performance.Stable radiomics features were predominantly texture-based,particularly gray-level cooccurrence matrix(GLCM)and gray-level run-length matrix(GLRLM)features derived from original and wavelet-filtered images.
Xiaoxuan Fan;Yanghan Chen;Junfeng Lin;Zenwen Han;Jianqiang Ye;Lili Lin;Hong Zhang;Ang Li;Han Jiang
PET Center,Fujian Medical University Union Hospital,Fuzhou,ChinaPET Center,Fujian Medical University Union Hospital,Fuzhou,ChinaPET Center,Fujian Medical University Union Hospital,Fuzhou,ChinaPET Center,Fujian Medical University Union Hospital,Fuzhou,China Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors,Fujian Medical University,Fuzhou,China Clinical Research Center for Radiology and Radiotherapy of Fujian Province(Digestive,Hematological and Breast Malignancies),Fuzhou,ChinaPET Center,Fujian Medical University Union Hospital,Fuzhou,China Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors,Fujian Medical University,Fuzhou,China Clinical Research Center for Radiology and Radiotherapy of Fujian Province(Digestive,Hematological and Breast Malignancies),Fuzhou,ChinaPET Center,Fujian Medical University Union Hospital,Fuzhou,China Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors,Fujian Medical University,Fuzhou,China Clinical Research Center for Radiology and Radiotherapy of Fujian Province(Digestive,Hematological and Breast Malignancies),Fuzhou,ChinaDepartment of Nuclear Medicine,Zhejiang Cancer Hospital,Hangzhou Institute of Medicine,Chinese Academy of Sciences,Hangzhou,China Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University,Hangzhou,China Key Laboratory of Medical Molecular Imaging of Zhejiang Province,Hangzhou,China Key Laboratory for Biomedical Engineering of Ministry of Education,Zhejiang University,Hangzhou,China College of Biomedical Engineering&Instrument Science,Zhejiang University,Hangzhou,ChinaPET Center,Fujian Medical University Union Hospital,Fuzhou,China Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors,Fujian Medical University,Fuzhou,China Clinical Research Center for Radiology and Radiotherapy of Fujian Province(Digestive,Hematological and Breast Malignancies),Fuzhou,ChinaPET Center,Fujian Medical University Union Hospital,Fuzhou,China Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors,Fujian Medical University,Fuzhou,China Clinical Research Center for Radiology and Radiotherapy of Fujian Province(Digestive,Hematological and Breast Malignancies),Fuzhou,China
医药卫生
dopamine transporter imagingmachine learningmotor progressionParkinson''s diseaseradiomics
《iRADIOLOGY》 2026 (3)
P.246-260,15
supported by the National Key Research and Development Program of China(Grant 2021YFA1101700)the Fundamental Research Funds for the Central Universities(Grant 226-2024-00059)the National Natural Science Foundation of China(Grant 82302263)Fujian Provincial Health Technology Project(Grant 2023GGA020)Fujian Provincial Natural Science Foundation of China(Grant 2024J01604)Joint Funds for the innovation of Science and Technology,Fujian province(Grant 2023Y9143)College Students''Innovative Entrepreneurial Training Plan Program of Fujian Medical University(Grant C2025052).
评论